- Home
- ASPI vs TNYA Comparison
ASPI vs TNYA Comparison
Compare ASPI & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPI
- TNYA
- Stock Information
- Founded
- ASPI 2021
- TNYA 2016
- Country
- ASPI United States
- TNYA United States
- Employees
- ASPI N/A
- TNYA N/A
- Industry
- ASPI Major Chemicals
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- ASPI Industrials
- TNYA Health Care
- Exchange
- ASPI Nasdaq
- TNYA Nasdaq
- Market Cap
- ASPI 158.4M
- TNYA 138.1M
- IPO Year
- ASPI 2022
- TNYA 2021
- Fundamental
- Price
- ASPI $8.77
- TNYA $2.76
- Analyst Decision
- ASPI Strong Buy
- TNYA Strong Buy
- Analyst Count
- ASPI 2
- TNYA 5
- Target Price
- ASPI $4.50
- TNYA $14.75
- AVG Volume (30 Days)
- ASPI 7.3M
- TNYA 3.6M
- Earning Date
- ASPI 11-19-2024
- TNYA 11-06-2024
- Dividend Yield
- ASPI N/A
- TNYA N/A
- EPS Growth
- ASPI N/A
- TNYA N/A
- EPS
- ASPI N/A
- TNYA N/A
- Revenue
- ASPI $2,295,679.00
- TNYA N/A
- Revenue This Year
- ASPI $1,760.86
- TNYA N/A
- Revenue Next Year
- ASPI $314.74
- TNYA $360.00
- P/E Ratio
- ASPI N/A
- TNYA N/A
- Revenue Growth
- ASPI N/A
- TNYA N/A
- 52 Week Low
- ASPI $1.11
- TNYA $1.61
- 52 Week High
- ASPI $9.23
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- ASPI 78.38
- TNYA 67.26
- Support Level
- ASPI $6.40
- TNYA $2.00
- Resistance Level
- ASPI $8.86
- TNYA $2.75
- Average True Range (ATR)
- ASPI 1.06
- TNYA 0.26
- MACD
- ASPI 0.27
- TNYA 0.09
- Stochastic Oscillator
- ASPI 90.44
- TNYA 71.76
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.